Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma

Shi Wang, L. Jeffrey Medeiros, Zijun Y. Xu-Monette, Shanxiang Zhang, Dennis P. O'Malley, Attilio Orazi, Zhuang Zuo, Carlos E. Bueso-Ramos, Cameron C. Yin, Zhiyu Liu, Roberto N. Miranda, Ken H. Young

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Hodgkin lymphoma (HL) is classified into 2 largely distinct subgroups, namely nodular lymphocyte predominant HL (NLPHL) and classic HL (CHL). CHL is further divided into nodular sclerosis, lymphocyte-rich, mixed cellularity (MCCHL) and lymphocyte-depleted (LDCHL) subtypes. In industrialized nations, Epstein-Barr virus (EBV) has been associated with all types of CHL, especially the MCCHL and LDCHL subtypes, but is rare in NLPHL. We report 8 cases of EBV-positive NLPHL occurring in patients in the United States. All 8 patients have no history of immunosuppression and presented with localized or systemic lymphadenopathy. Histologically, 6 cases had a vaguely nodular pattern and 2 cases had a nodular and diffuse pattern. In all cases, lymphocyte predominant (LP) cells were observed in a background of small lymphocytes and histiocytes. Immunohistochemical analysis showed that the LP cells in all cases were positive for CD20, CD79a, PAX5, OCT2, and CD45 and were negative for CD15. CD30 was expressed variably in 7 cases. EBV encoded RNA was present in all LP cells in 5 cases and in a subset of LP cells in 3 cases. One patient was treated with radiation therapy and 7 patients received chemotherapy, including 4 of 7 patients who underwent autologous stem cell transplantation. EBV infection is a rare primary or secondary event in NLPHL that correlates with poorer prognosis and often requires more aggressive therapy. The variable expression of CD30 in most of these cases could be the result of EBV infection.

Original languageEnglish (US)
Pages (from-to)203-209
Number of pages7
JournalAnnals of Diagnostic Pathology
Volume18
Issue number4
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Human Herpesvirus 4
Hodgkin Disease
Lymphocytes
Epstein-Barr Virus Infections
Histiocytes
Lymphocyte Subsets
Stem Cell Transplantation
Sclerosis
Developed Countries
Immunosuppression
Radiotherapy
RNA
Drug Therapy

Keywords

  • Classical Hodgkin lymphoma
  • Epstein-Barr virus
  • Nodular lymphocyte predominant Hodgkin lymphoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Wang, S., Medeiros, L. J., Xu-Monette, Z. Y., Zhang, S., O'Malley, D. P., Orazi, A., ... Young, K. H. (2014). Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma. Annals of Diagnostic Pathology, 18(4), 203-209. https://doi.org/10.1016/j.anndiagpath.2014.03.007

Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma. / Wang, Shi; Medeiros, L. Jeffrey; Xu-Monette, Zijun Y.; Zhang, Shanxiang; O'Malley, Dennis P.; Orazi, Attilio; Zuo, Zhuang; Bueso-Ramos, Carlos E.; Yin, Cameron C.; Liu, Zhiyu; Miranda, Roberto N.; Young, Ken H.

In: Annals of Diagnostic Pathology, Vol. 18, No. 4, 01.01.2014, p. 203-209.

Research output: Contribution to journalArticle

Wang, S, Medeiros, LJ, Xu-Monette, ZY, Zhang, S, O'Malley, DP, Orazi, A, Zuo, Z, Bueso-Ramos, CE, Yin, CC, Liu, Z, Miranda, RN & Young, KH 2014, 'Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma', Annals of Diagnostic Pathology, vol. 18, no. 4, pp. 203-209. https://doi.org/10.1016/j.anndiagpath.2014.03.007
Wang, Shi ; Medeiros, L. Jeffrey ; Xu-Monette, Zijun Y. ; Zhang, Shanxiang ; O'Malley, Dennis P. ; Orazi, Attilio ; Zuo, Zhuang ; Bueso-Ramos, Carlos E. ; Yin, Cameron C. ; Liu, Zhiyu ; Miranda, Roberto N. ; Young, Ken H. / Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma. In: Annals of Diagnostic Pathology. 2014 ; Vol. 18, No. 4. pp. 203-209.
@article{d89889432d6145b0ba6588d2778b1e92,
title = "Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma",
abstract = "Hodgkin lymphoma (HL) is classified into 2 largely distinct subgroups, namely nodular lymphocyte predominant HL (NLPHL) and classic HL (CHL). CHL is further divided into nodular sclerosis, lymphocyte-rich, mixed cellularity (MCCHL) and lymphocyte-depleted (LDCHL) subtypes. In industrialized nations, Epstein-Barr virus (EBV) has been associated with all types of CHL, especially the MCCHL and LDCHL subtypes, but is rare in NLPHL. We report 8 cases of EBV-positive NLPHL occurring in patients in the United States. All 8 patients have no history of immunosuppression and presented with localized or systemic lymphadenopathy. Histologically, 6 cases had a vaguely nodular pattern and 2 cases had a nodular and diffuse pattern. In all cases, lymphocyte predominant (LP) cells were observed in a background of small lymphocytes and histiocytes. Immunohistochemical analysis showed that the LP cells in all cases were positive for CD20, CD79a, PAX5, OCT2, and CD45 and were negative for CD15. CD30 was expressed variably in 7 cases. EBV encoded RNA was present in all LP cells in 5 cases and in a subset of LP cells in 3 cases. One patient was treated with radiation therapy and 7 patients received chemotherapy, including 4 of 7 patients who underwent autologous stem cell transplantation. EBV infection is a rare primary or secondary event in NLPHL that correlates with poorer prognosis and often requires more aggressive therapy. The variable expression of CD30 in most of these cases could be the result of EBV infection.",
keywords = "Classical Hodgkin lymphoma, Epstein-Barr virus, Nodular lymphocyte predominant Hodgkin lymphoma",
author = "Shi Wang and Medeiros, {L. Jeffrey} and Xu-Monette, {Zijun Y.} and Shanxiang Zhang and O'Malley, {Dennis P.} and Attilio Orazi and Zhuang Zuo and Bueso-Ramos, {Carlos E.} and Yin, {Cameron C.} and Zhiyu Liu and Miranda, {Roberto N.} and Young, {Ken H.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.anndiagpath.2014.03.007",
language = "English (US)",
volume = "18",
pages = "203--209",
journal = "Annals of Diagnostic Pathology",
issn = "1092-9134",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma

AU - Wang, Shi

AU - Medeiros, L. Jeffrey

AU - Xu-Monette, Zijun Y.

AU - Zhang, Shanxiang

AU - O'Malley, Dennis P.

AU - Orazi, Attilio

AU - Zuo, Zhuang

AU - Bueso-Ramos, Carlos E.

AU - Yin, Cameron C.

AU - Liu, Zhiyu

AU - Miranda, Roberto N.

AU - Young, Ken H.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Hodgkin lymphoma (HL) is classified into 2 largely distinct subgroups, namely nodular lymphocyte predominant HL (NLPHL) and classic HL (CHL). CHL is further divided into nodular sclerosis, lymphocyte-rich, mixed cellularity (MCCHL) and lymphocyte-depleted (LDCHL) subtypes. In industrialized nations, Epstein-Barr virus (EBV) has been associated with all types of CHL, especially the MCCHL and LDCHL subtypes, but is rare in NLPHL. We report 8 cases of EBV-positive NLPHL occurring in patients in the United States. All 8 patients have no history of immunosuppression and presented with localized or systemic lymphadenopathy. Histologically, 6 cases had a vaguely nodular pattern and 2 cases had a nodular and diffuse pattern. In all cases, lymphocyte predominant (LP) cells were observed in a background of small lymphocytes and histiocytes. Immunohistochemical analysis showed that the LP cells in all cases were positive for CD20, CD79a, PAX5, OCT2, and CD45 and were negative for CD15. CD30 was expressed variably in 7 cases. EBV encoded RNA was present in all LP cells in 5 cases and in a subset of LP cells in 3 cases. One patient was treated with radiation therapy and 7 patients received chemotherapy, including 4 of 7 patients who underwent autologous stem cell transplantation. EBV infection is a rare primary or secondary event in NLPHL that correlates with poorer prognosis and often requires more aggressive therapy. The variable expression of CD30 in most of these cases could be the result of EBV infection.

AB - Hodgkin lymphoma (HL) is classified into 2 largely distinct subgroups, namely nodular lymphocyte predominant HL (NLPHL) and classic HL (CHL). CHL is further divided into nodular sclerosis, lymphocyte-rich, mixed cellularity (MCCHL) and lymphocyte-depleted (LDCHL) subtypes. In industrialized nations, Epstein-Barr virus (EBV) has been associated with all types of CHL, especially the MCCHL and LDCHL subtypes, but is rare in NLPHL. We report 8 cases of EBV-positive NLPHL occurring in patients in the United States. All 8 patients have no history of immunosuppression and presented with localized or systemic lymphadenopathy. Histologically, 6 cases had a vaguely nodular pattern and 2 cases had a nodular and diffuse pattern. In all cases, lymphocyte predominant (LP) cells were observed in a background of small lymphocytes and histiocytes. Immunohistochemical analysis showed that the LP cells in all cases were positive for CD20, CD79a, PAX5, OCT2, and CD45 and were negative for CD15. CD30 was expressed variably in 7 cases. EBV encoded RNA was present in all LP cells in 5 cases and in a subset of LP cells in 3 cases. One patient was treated with radiation therapy and 7 patients received chemotherapy, including 4 of 7 patients who underwent autologous stem cell transplantation. EBV infection is a rare primary or secondary event in NLPHL that correlates with poorer prognosis and often requires more aggressive therapy. The variable expression of CD30 in most of these cases could be the result of EBV infection.

KW - Classical Hodgkin lymphoma

KW - Epstein-Barr virus

KW - Nodular lymphocyte predominant Hodgkin lymphoma

UR - http://www.scopus.com/inward/record.url?scp=84904260805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904260805&partnerID=8YFLogxK

U2 - 10.1016/j.anndiagpath.2014.03.007

DO - 10.1016/j.anndiagpath.2014.03.007

M3 - Article

VL - 18

SP - 203

EP - 209

JO - Annals of Diagnostic Pathology

JF - Annals of Diagnostic Pathology

SN - 1092-9134

IS - 4

ER -